Todd M. DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc./tx (NASDAQ:CORZ), filed a Form 4 on August 12, 2026, disclosing the sale of 10,000 shares of common stock on August 10, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Todd M. DuChene, identified in the filing as Chief Legal and Administrative Officer of Core Scientific, Inc./tx.
  • First sale: 9,000 shares disposed of on August 10, 2026, at a weighted average price of $19.8986, with individual transaction prices ranging from $19.45 to $20.44.
  • Second sale: 1,000 shares disposed of on August 10, 2026, at a weighted average price of $20.648, with individual transaction prices ranging from $20.47 to $20.89.
  • Post-transaction ownership: DuChene directly held 1,969,101 shares of common stock following the reported transactions.
  • Trading plan: Both transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by DuChene on December 5, 2025.
  • Ownership form: All shares are held directly by the reporting person.

Core Scientific Officer's Share Sales Under Pre-Planned Trading Program

According to the filing, DuChene sold a total of 10,000 shares of Core Scientific, Inc./tx common stock on August 10, 2026, across two separate transactions. The first transaction involved 9,000 shares sold at a weighted average price of $19.8986 per share. The filing notes that these shares were sold in multiple transactions at prices ranging from $19.45 to $20.44, inclusive. After this transaction, DuChene's direct beneficial ownership stood at 1,970,101 shares.

The second transaction on the same date involved 1,000 additional shares disposed of at a weighted average price of $20.648 per share, with individual prices ranging from $20.47 to $20.89, inclusive, according to the filing. Following both transactions, DuChene's total direct beneficial ownership was reported as 1,969,101 shares of Core Scientific common stock. The filing discloses that DuChene "undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."

The filing indicates that both sales were made pursuant to a Rule 10b5-1 trading plan that DuChene adopted on December 5, 2025. Core Scientific, Inc./tx is listed on NASDAQ under the ticker symbol CORZ. The Form 4 was signed by DuChene and dated August 12, 2026. No derivative securities were reported as acquired, disposed of, or beneficially owned in connection with these transactions.

What Was Disclosed

The filing reports two open-market sales of Core Scientific common stock by the company's Chief Legal and Administrative Officer on August 10, 2026, totaling 10,000 shares sold under a pre-established Rule 10b5-1 plan adopted December 5, 2025, leaving the officer with 1,969,101 shares held directly.